FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

Carriers of Genetic Mutation at 1.7 Times Greater Risk for Multiple Sclerosis



Image source: EXTREMETECH

Women with a specific genetic variation have a significantly greater chance of developing multiple sclerosis (MS), according to research published in the journal ASN Neuro.

Researchers from the University of Illinois at Chicago observed a family of 5 siblings in order to test the association between MS and the genetic variation which contributes to Peutz Jeghers Syndrome, a rare autosomal dominant disease caused by mutations in the serine threonine kinase 11 (STK11). The sisters were between the ages of 23 and 26 years, and all were diagnosed with MS. The variant was present in the 3 siblings (including twins) that were tested. Similar, but not identical, genetic variants were discovered in the other 2 siblings as well.

These findings were called “one of the strongest genetic risk factors for MS discovered to date,” by senior author Doug Feinstein, PhD, in a press release.

When study coordinator Anne Boullerne learned from a casual conversation with one of the women involved in the study that she and all 4 of her siblings had MS, she was intrigued.

“I was immediately interested in the possibility of a genetic study of the family because all 5 siblings – an entire generation – are affected by MS, and so we could have a very good chance of discovering key genes related to inheritance of the disease,” Boullerne said.

The researchers conducted a complete DNA sequencing of the original sibling’s genome, and closely examined the STK11 gene. The woman’s twin sisters carried the same genetic variant.

In the next phase of the study, the researchers wanted to determine if single nucleotide polymorphism (SNP), the genetic variant they had previously identified, in fact contributed to MS in the siblings. They screened DNA samples from 750 MS patients and 650 healthy patients. For women SNP carriers ,the prevalence of MS was 1.7 times higher than women without MS.

The researchers estimated that STK11 SNP is present in about 7 percent of the general population, based on extrapolations from their data. But, Feinstein said, far fewer people develop MS. This means that other factors play into risk and development of MS, and whether they are genetic or non genetic is yet to be determined.

The researchers next want to screen the DNA of the 5 siblings’ parents to continue looking for other genetic factors that contribute to MS. In the future, they will additionally investigate the purpose of the STK11 gene in the lab. They hope to pinpoint the molecular pathways involved in MS development.


Story Source: The above story is based on materials provided by HCPLIVE
Note: Materials may be edited for content and length


Go to Newer News Go to Older News